NovAseptic AB
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
NovAseptic AB - overview
Established
1993
Location
-, -, Sweden
Primary Industry
Biotechnology
About
Founded in 1993 and based in Sweden, NovAseptic AB operates as a provider of solutions for aseptic processing applications in biotech and pharmaceutical manufacturing operations, including disposable sampling system, mixers, valves, and connectors.
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Medical Devices & Equipment, Pharmaceuticals
Company Stage
Acquired
Total Amount Raised
Subscriber access only
NovAseptic AB - financials
| Fiscal Year Ended | Apr 30, 2001 | Apr 30, 2002 | Apr 30, 2003 | Apr 30, 2004 | Dec 31, 2005 |
|---|---|---|---|---|---|
| Revenue (USD) | 79,918,000 | 125,447,000 | - | - | - |
| % Revenue Growth (YoY) | - | 57.0% | - | - | - |
| EBITDA (USD) | 9,125,000 | 17,577,000 | - | - | - |
| Operating Income (USD) | 7,766,000 | 15,703,000 | - | - | - |
| Operating Margin | 9.7% | 12.5% | - | - | - |
| % EBITDA Margin | 11.4% | 14.0% | - | - | - |
| NET Income (USD) | 4,624,000 | 9,328,000 | - | - | - |
| % Net Margin | 5.8% | 7.4% | - | - | - |
NovAseptic AB - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | NovAseptic AB | - | ||||||||
| Buyout | Completed | NovAseptic AB | - |
Displaying 1 - 2 of 2
NovAseptic AB - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.